Skip to content

Preliminary study testing the ReCoVRY Virtual Reality-application as an adjuvant AUD therapy in the inpatient immediate post detoxification phase. A new Coaching Application based on Virtual Reality Exposure.

Preliminary study testing the ReCoVRY Virtual Reality-application as an adjuvant AUD therapy in the inpatient immediate post detoxification phase. A new Coaching Application based on Virtual Reality Exposure. - The ReCoVRY Virtual Reality-application as an adjuvant AUD therapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48455
Enrollment
48
Registered
2019-07-09
Start date
2019-07-17
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

verslaving namelijk stoornissen in alcoholgebruik alchol dependency alcohol use disorder

Interventions

In the last week of their inpatient detoxification program patients of both the 360° and animated VR groups will have three 30 minutes VR session (day 1,4 and 7) in which they will be confronted wit

Sponsors

Novadic-Kentron (Sint Oedenrode)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: a) Primary dependence of alcohol, (b) Age between 18 and 65 years and (c) Sufficient understanding of the Dutch language.

Exclusion criteria

Exclusion criteria: (a) Severe psychiatric disorders like severe psychosis and suicidal ideations (issues); (b) severe poly-drug use (in such a way that it interfers with the treatment); (c) severe physical diseases (cardiovascular diseases, COPD etc.),(d) mentally incompetent and (e) pregnancy.

Design outcomes

Primary

MeasureTime frame
In the present study a quasi-experimental study is proposed. This study provides more insights in the experience and acceptance of the use of an VR-application as an adjuvant in the inpatient treatment of AUD patients. The main study parameter is the experience and acceptance to use a VR app by AUD patient in an inpatient treatment program.

Secondary

MeasureTime frame
Furthermore the study will focus on the level of realism, operationalized in two different types of VR environments (360° recordings versus computer generated virtual worlds) that is experienced by the participants. In addition, the satisfaction and side effects as the level of self-efficacy and of craving experienced by the participants will be measured. The last two will be measured before and immediately after the VR-sessions. The dmCV (a hybrid measure of the SSQ and subjective symptoms of craving to differentiate from both) will be used for the exploration before (first base line measure) and after the three sessions. The satisfaction will be measured only after the last session.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)